{"DataElement":{"publicId":"14765184","version":"1","preferredName":"Multiplex Imaging Antibody Name","preferredDefinition":"A proprietary technology platform that uses a known set of oligonucleotide barcodes in combination with methods for assessing single cell gene expression using barcode-conjugated primers, detecting cell surface expression of proteins via capture with barcode-conjugated antibodies, mapping of B-cell and T-cell receptor targets through tagging with barcode-conjugated antigens and targeted analysis of promoter effects on gene expression via CRISPR perturbation with barcode-conjugated guide RNAs.:A type of protein made by B lymphocytes in response to a foreign substance (antigen). Each antibody only binds to a specific antigen, helping to destroy the antigen directly or by assisting white blood cells to destroy the antigen.:The words or language units by which a thing is known.","longName":"14765183v1.00:5406151v1.00","context":"CRDC","contextVersion":"1","DataElementConcept":{"publicId":"14765183","version":"1","preferredName":"Multiplex Imaging Antibody","preferredDefinition":"A proprietary technology platform that uses a known set of oligonucleotide barcodes in combination with methods for assessing single cell gene expression using barcode-conjugated primers, detecting cell surface expression of proteins via capture with barcode-conjugated antibodies, mapping of B-cell and T-cell receptor targets through tagging with barcode-conjugated antigens and targeted analysis of promoter effects on gene expression via CRISPR perturbation with barcode-conjugated guide RNAs.:A type of protein made by B lymphocytes in response to a foreign substance (antigen). Each antibody only binds to a specific antigen, helping to destroy the antigen directly or by assisting white blood cells to destroy the antigen.","longName":"14765173v1.00:2594488v1.00","context":"CRDC","contextVersion":"1","ObjectClass":{"publicId":"14765173","version":"1","preferredName":"Feature Barcoding","preferredDefinition":"A proprietary technology platform that uses a known set of oligonucleotide barcodes in combination with methods for assessing single cell gene expression using barcode-conjugated primers, detecting cell surface expression of proteins via capture with barcode-conjugated antibodies, mapping of B-cell and T-cell receptor targets through tagging with barcode-conjugated antigens and targeted analysis of promoter effects on gene expression via CRISPR perturbation with barcode-conjugated guide RNAs.","longName":"C202255","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Feature Barcoding","conceptCode":"C202255","definition":"A proprietary technology platform that uses a known set of oligonucleotide barcodes in combination with methods for assessing single cell gene expression using barcode-conjugated primers, detecting cell surface expression of proteins via capture with barcode-conjugated antibodies, mapping of B-cell and T-cell receptor targets through tagging with barcode-conjugated antigens and targeted analysis of promoter effects on gene expression via CRISPR perturbation with barcode-conjugated guide RNAs.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"11C47AEA-59FC-38C8-E063-731AD00A6875","latestVersionIndicator":"Yes","beginDate":"2024-02-19","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2024-02-19","modifiedBy":"FINCHAMB","dateModified":"2024-02-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2594488","version":"1","preferredName":"Antibody","preferredDefinition":"(AN-tih-BOD-ee) A type of protein made by certain white blood cells in response to a foreign substance (antigen). Each antibody can bind to only a specific antigen. The purpose of this binding is to help destroy the antigen. Antibodies can work in several ways, depending on the nature of the antigen. Some antibodies destroy antigens directly. Others make it easier for white blood cells to destroy the antigen.","longName":"C16295","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Antibody","conceptCode":"C16295","definition":"A type of protein made by B lymphocytes in response to a foreign substance (antigen). Each antibody only binds to a specific antigen, helping to destroy the antigen directly or by assisting white blood cells to destroy the antigen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"292952CD-4FC4-132B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-02-10","endDate":null,"createdBy":"IVERSONJ","dateCreated":"2007-02-10","modifiedBy":"ONEDATA","dateModified":"2007-02-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2233241","version":"1","preferredName":"Medical Imaging","preferredDefinition":"Events, people, materials and activities uniquely defined by medical imaging.  ","longName":"MEDICAL IMAGING","context":"CIP","contextVersion":"2.31","origin":"DICOM:Digital Imaging and Communications in Medicine","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F96173D7-A9B4-3CBB-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-06-12","modifiedBy":"SBREXT","dateModified":"2006-09-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CDS:Cancer Data Service","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"11D1A5A0-0900-47DA-E063-731AD00A1CB8","latestVersionIndicator":"Yes","beginDate":"2024-02-20","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2024-02-20","modifiedBy":"FINCHAMB","dateModified":"2024-02-21","changeDescription":null,"administrativeNotes":"2/20/24 Created for CDS Imaging. BF","unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"5406151","version":"1","preferredName":"Name","preferredDefinition":"The words or language units by which a thing is known.","longName":"5406151v1.0","context":"NCI Standards","contextVersion":"1","type":"Non-enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2230266","version":"1","preferredName":"Tissue Banking","preferredDefinition":"Concepts linked to Tissue Banking and Pathology activities","longName":"TISSUE BANKING","context":"SPOREs","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F78BDEC8-6723-436F-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-05-20","modifiedBy":"REEVESD","dateModified":"2005-05-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2229718","version":"1","preferredName":"Name","preferredDefinition":"The words or language units by which a thing is known.","longName":"C42614","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Name","conceptCode":"C42614","definition":"The words or language units by which a thing is known.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F6EF4E2B-76AE-72C1-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-16","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-05-16","modifiedBy":"ONEDATA","dateModified":"2005-05-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"BPV: Biospecimen Pre-analytical Variables (BPV) Program","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"39E4FF51-6546-DA89-E050-BB89AD4323AC","latestVersionIndicator":"Yes","beginDate":"2016-08-12","endDate":null,"createdBy":"TAYLORT","dateCreated":"2016-08-12","modifiedBy":"KNABLEJ","dateModified":"2020-10-13","changeDescription":"10/13/20 jk remove MCL Genomic CSI.  7-8-18 tt added MCL CSI. 11/19/18 jk added MCL CSI reference.  8/3/17 tt transferred to NCI Standards per confirmation by Gwen Dean, added CSI and reg status per Round 5 finalization task.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"8064110","version":"1","longName":"CDS (Cancer Data Service)","context":"CRDC","ClassificationSchemeItems":[{"publicId":"14470388","version":"1","longName":"Imaging","context":"CRDC"}]}],"AlternateNames":[{"name":"antibody_name","type":"CDS Alt Name","context":"CRDC"}],"ReferenceDocuments":[{"name":"PQT","type":"Preferred Question Text","description":"Data Element Multiplex Imaging Antibody Name does not have Preferred Question Text.","url":null,"context":"CRDC"},{"name":"CDS Example","type":"EXAMPLE","description":"free text (“Keratin-570”, “CD8a-488”)","url":null,"context":"CRDC"}],"origin":"CDS:Cancer Data Service","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"11D1B071-EB74-49BB-E063-731AD00ACB76","latestVersionIndicator":"Yes","beginDate":"2024-02-20","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2024-02-20","modifiedBy":"FINCHAMB","dateModified":"2024-02-21","changeDescription":null,"administrativeNotes":"2/20/24 Created for CDS Imaging. BF","unresolvedIssues":null,"deletedIndicator":"No"}}